Located in Shanghai, China, is a high-technology enterprise with the mission of clinically translational advancement
of novel medicine and therapeutics for global pharmaceuticals

Headquartered in the Fengxian Biological S&T Park, is a brand-new and top-equipped NHP study facility centered
with clinical specialties, disease models, and NHP pharmacology expertise, in alignment with the caliber and scale
of pharma and biotech industries

Pioneered in NHP pharmacology, is a professional team focusing on non-, pre- and peri-clinical studies of
new drugs, drugging technologies, and applications, grounded on NHP cross-reactions, in normal and
pathological conditions, and in the therapeutic endpoints, with the human patients